ASCML
XBI icon

ADKINS SEALE CAPITAL MANAGEMENT LLC’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

ADKINS SEALE CAPITAL MANAGEMENT LLC’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38K Hold
240
– – 0.03% 152
2026
Q1 		$30.7K Hold
240
– – 0.03% 153
2025
Q4 		$29.3K Buy
+240
New +$27.5K 0.03% 154

Other funds holding XBI

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return
MSR
Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
WT
Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return
AAS
Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return
WJWM
Williams Jones Wealth Management New York $8.86B AUM 22.16% 1-Year Est. Return
G
GenTrust Miami, Florida $2.6B AUM 18.42% 1-Year Est. Return

ADKINS SEALE CAPITAL MANAGEMENT LLC's XBI Position: Q2 2026 in Review

ADKINS SEALE CAPITAL MANAGEMENT LLC held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 240 shares worth $38K. The position accounts for 0.03% of the portfolio, ranked #152.

ADKINS SEALE CAPITAL MANAGEMENT LLC first reported a position in XBI in Q4 2025 and has held it in 3 quarters since. 519 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • ADKINS SEALE CAPITAL MANAGEMENT LLC held 240 shares of State Street SPDR S&P Biotech ETF worth $38K as of Q2 2026.
  • ADKINS SEALE CAPITAL MANAGEMENT LLC left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
  • State Street SPDR S&P Biotech ETF made up 0.03% of ADKINS SEALE CAPITAL MANAGEMENT LLC's portfolio in Q2 2026, its #152 holding.
  • ADKINS SEALE CAPITAL MANAGEMENT LLC first reported a position in State Street SPDR S&P Biotech ETF in Q4 2025 and has held it in 3 quarters since.
  • 519 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on ADKINS SEALE CAPITAL MANAGEMENT LLC's 13F filing for Q2 2026, filed 5 Aug 2026.